Emerging Biomarkers for Drug Development in Amyotrophic Lateral Sclerosis

被引：1
|
作者：
Cavallaro, Sebastiano [1 ]
机构：
[1] Italian Natl Res Council, Inst Neurol Sci, I-95125 Catania, Italy
来源：
CURRENT MEDICINAL CHEMISTRY | 2014年 / 21卷 / 31期
关键词：
D O I：
10.2174/092986732131140918141824
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：3507 / 3507
页数：1
相关论文
共 50 条
  • [41] Biomarkers in Amyotrophic Lateral Sclerosis: Is There A Neurovascular Pathway?
    Bhutani, Himshikha
    Anand, Akshay
    CURRENT NEUROVASCULAR RESEARCH, 2012, 9 (04) : 302 - 309
  • [42] Fluid biomarkers for amyotrophic lateral sclerosis: a review
    Katherine E. Irwin
    Udit Sheth
    Philip C. Wong
    Tania F. Gendron
    Molecular Neurodegeneration, 19
  • [43] Mechanisms, models and biomarkers in amyotrophic lateral sclerosis
    Turner, Martin R.
    Bowser, Robert
    Bruijn, Lucie
    Dupuis, Luc
    Ludolph, Albert
    McGrath, Michael
    Manfredi, Giovanni
    Maragakis, Nicholas
    Miller, Robert G.
    Pullman, Seth L.
    Rutkove, Seward B.
    Shaw, Pamela J.
    Shefner, Jeremy
    Fischbeck, Kenneth H.
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2013, 14 : 19 - 32
  • [44] Diagnostic biomarkers for amyotrophic lateral sclerosis (ALS)
    Bowser, R
    Ranganathan, S
    Ganchev, P
    Gopalakrishnan, V
    Cudkowicz, M
    Brown, RH
    FASEB JOURNAL, 2005, 19 (05): : A1511 - A1511
  • [45] Emerging targets and treatments in amyotrophic lateral sclerosis
    Zinman, Lorne
    Cudkowicz, Merit
    LANCET NEUROLOGY, 2011, 10 (05): : 481 - 490
  • [46] Emerging concepts and therapies for amyotrophic lateral sclerosis
    Kiernan, Matthew C.
    Kaji, Ryuji
    CURRENT OPINION IN NEUROLOGY, 2024, 37 (05) : 558 - 559
  • [47] Current and emerging treatments for amyotrophic lateral sclerosis
    Zoccolella, Stefano
    Santamato, Andrea
    Lamberti, Paolo
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2009, 5 : 577 - 595
  • [48] Neurodegenerative biomarkers outperform neuroinflammatory biomarkers in amyotrophic lateral sclerosis
    Klappe, Ulf
    Sennfalt, Stefan
    Lovik, Aniko
    Finn, Anja
    Bofaisal, Ulrika
    Zetterberg, Henrik
    Blennow, Kaj
    Piehl, Fredrik
    Kmezic, Ivan
    Press, Rayomand
    Samuelsson, Kristin
    Manberg, Anna
    Fang, Fang
    Ingre, Caroline
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2024, 25 (1-2) : 150 - 161
  • [49] Drug development for amyotrophic lateral sclerosis: lessons from cancer therapy
    Kaye, S
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1998, : 6 - 8
  • [50] Potential new complication in drug therapy development for amyotrophic lateral sclerosis
    Garbuzova-Davis, Svitlana
    Thomson, Avery
    Kurien, Crupa
    Shytle, R. Douglas
    Sanberg, Paul R.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (12) : 1397 - 1405
12345